Résultats de la recherche
10
Tout
Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025
06 mars 2025 07h00 HE
|
Autolus Therapeutics plc
Autolus will report Q4 and FY 2024 financial results and operational updates on March 20, 2025.
Autolus Therapeutics to Participate in Upcoming Investor Conferences
05 mars 2025 07h00 HE
|
Autolus Therapeutics plc
Autolus will participate in two upcoming investor conferences: Jefferies Biotech on the Beach and Leerink Global Biopharma Conference.
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
09 déc. 2024 19h30 HE
|
Autolus Therapeutics plc
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
Autolus Therapeutics Announces Publication of Data from the FELIX study of obe-cel in r/r Adult B-ALL Patients in The New England Journal of Medicine
02 déc. 2024 07h00 HE
|
Autolus Therapeutics plc
High overall response rate: 76.6% of patients in the pivotal cohort achieved CR/Cri following treatment with obe-cel with a median follow-up of 20.3 monthsLow incidence of immune-related toxicity:...
Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates
12 nov. 2024 07h00 HE
|
Autolus Therapeutics plc
Autolus Therapeutics Reports Third Quarter 2024 Financial Results
and Business Updates
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations
05 nov. 2024 09h00 HE
|
Autolus Therapeutics plc
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
28 oct. 2024 17h00 HE
|
Autolus Therapeutics plc
Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress
16 oct. 2024 09h00 HE
|
Autolus Therapeutics plc
Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
19 sept. 2024 07h00 HE
|
Autolus Therapeutics plc
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024
27 août 2024 07h00 HE
|
Autolus Therapeutics plc
Autolus presents clinical data update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024